protect
clinic
diseas
prevent
renal
carrier
state
remain
key
object
vaccin
leptospirosi
dog
present
paper
group
dog
vaccin
twice
commerci
bacterin
eurican
l
contain
leptospira
interrogan
serovar
icterohaemorrhagia
canicola
challeng
heterolog
repres
serovar
week
onset
immun
month
durat
immun
second
vaccin
control
dog
vaccin
leptospirosi
kept
vaccin
dog
challeng
irrespect
serovar
reliabl
produc
clinic
sign
consist
leptospira
infect
control
pup
mortal
expect
clinic
diseas
adult
control
less
sever
abl
induc
morbid
mortal
well
extrem
challeng
condit
clinic
sign
vaccin
dog
rare
observ
mild
transient
natur
follow
experiment
infect
control
pup
adult
control
becam
renal
carrier
despit
heavi
challeng
none
vaccin
puppi
onset
immun
studi
vaccin
adult
dog
durat
immun
studi
develop
renal
carrier
state
result
show
primari
cours
two
dose
eurican
l
provid
quick
onset
longterm
protect
clinic
leptospirosi
renal
carrier
stage
vaccin
provid
veterinarian
power
tool
prevent
clinic
diseas
dog
zoonot
transmiss
leptospirosi
human
elsevi
bv
right
reserv
diseas
control
trevejo
et
al
leptospira
l
interrogan
serovar
icterohaemorrhagia
canicola
two
serovar
tradit
associ
diseas
dog
hartman
trevejo
et
al
new
serovar
play
increasingli
import
role
scanziani
et
al
ward
et
al
moor
et
al
geisen
et
al
stoke
et
al
henc
leptospirosi
recognis
import
reemerg
diseas
dog
bolin
ward
et
al
shortterm
clinic
protect
demonstr
experiment
dog
vaccin
sever
vaccin
huhn
et
al
fontain
et
al
klaasen
et
al
schreiber
et
al
b
much
debat
whether
leptospirosi
vaccin
protect
renal
carrier
state
fontain
et
al
provid
longterm
immun
coyn
et
al
far
know
first
demonstr
month
durat
immun
l
interrogan
serovar
canicola
provid
classic
bacterin
tronel
et
al
sinc
one
paper
publish
demonstr
durat
immun
month
commerci
bacterin
current
studi
confirm
extend
previou
observ
demonstr
two
dose
eurican
l
provid
rapid
onset
durat
protect
immun
least
month
serovar
icterohaemorrhagia
canicola
vaccin
evalu
protect
clinic
diseas
prevent
renal
carrier
state
four
separ
vaccinationchalleng
experi
includ
puppi
perform
studi
onset
durat
immun
provid
eurican
l
refer
studi
tabl
studi
contain
nine
vaccin
eight
control
studi
nine
vaccin
ten
control
studi
seven
vaccin
eight
control
studi
nine
vaccin
ten
control
tabl
institut
anim
care
use
committe
approv
obtain
conduct
studi
studi
puppi
vaccin
twice
subcutan
week
apart
puppi
week
age
time
first
vaccin
dog
studi
challeng
l
interrogan
serovar
canicola
week
month
respect
primari
vaccin
program
two
dose
dog
studi
challeng
l
interrogan
serovar
icterohaemorrhagia
week
month
respect
second
vaccin
primari
vaccin
cours
difficult
induc
clinic
leptospirosi
adult
dog
two
pup
ad
studi
time
challeng
assess
sever
infect
follow
challeng
dog
examin
presenc
clinic
sign
characterist
leptospirosi
leptospir
isol
blood
urin
sampl
collect
regular
interv
kidney
liver
studi
sampl
asept
taken
necropsi
blood
also
sampl
serolog
hematolog
biochem
analysi
studi
end
observ
period
death
dog
necropsi
organ
remov
histolog
examin
routin
product
batch
eurican
l
merial
lyon
franc
whole
cell
nonadjuv
vaccin
prepar
inactiv
cultur
l
interrogan
serovar
icterohaemorrhagia
canicola
use
batch
compli
potenc
requir
monograph
european
pharmacopoiea
studi
vaccin
administ
simultan
separ
site
vaccin
contain
recombin
canin
distemp
viru
modifi
live
canin
adenoviru
type
canin
parvoviru
canin
coronaviru
canin
parainfluenza
type
viru
studi
eurican
l
use
diluent
reconstitut
freezedri
pellet
contain
modifi
live
canin
distemp
viru
canin
adenoviru
type
canin
parvoviru
canin
parainfluenza
type
viru
second
combin
vaccin
commerci
name
eurican
seventyfour
specif
pathogen
free
spf
male
femal
beagl
pup
purchas
harlan
spragu
dawley
indianapoli
usa
zeist
netherland
ferm
de
goutt
charl
river
laboratori
inc
franc
dog
barrier
maintain
fed
highqual
commerci
dri
ration
unlimit
access
water
dog
identifi
microchip
implant
subcutan
andor
ear
tattoo
l
interrogan
serovar
canicola
strain
moulton
nation
veterinari
servic
laboratori
nvsl
ame
ia
usa
use
challeng
inoculum
studi
l
interrogan
serovar
icterohaemorrhagia
strain
cfi
nvsl
strain
pasteur
institut
pari
franc
use
challeng
inocula
studi
respect
ident
serovar
confirm
pasteur
institut
pari
franc
use
restrict
fragment
analysi
initi
cultur
ellinghausenmcculloughjohnsonharri
emjh
medium
strain
backpassag
twice
studi
four
time
studi
hamster
prevent
loss
virul
adapt
cultur
condit
moribund
hamster
human
euthanis
liver
kidney
spleen
studi
asept
remov
homogen
steril
salin
sediment
centrifug
supernat
dilut
steril
salin
inocul
dog
studi
dog
receiv
ml
challeng
suspens
contain
approxim
organ
l
interrogan
serovar
icterohaemorrhagia
canicola
respect
intraperiton
rout
studi
harvest
challeng
strain
passag
vitro
emjh
medium
allow
precis
quantif
bacteri
suspens
dog
receiv
ml
studi
ml
challeng
suspens
ml
instil
ventral
conjunctiv
sac
eye
remaind
administ
intraperiton
total
challeng
dose
per
dog
organ
l
interrogan
serovar
icterohaemorrhagia
canicola
respect
anim
observ
daili
day
studi
day
studi
challeng
sign
consist
leptospirosi
includ
depress
anorexia
conjunct
iriti
vomit
diarrhoea
jaundic
petechia
sign
urinari
diseas
haematuria
sign
score
use
standard
protocol
tabl
rectal
temperatur
taken
record
daili
day
challeng
temperatur
consid
hyperthermia
dog
studi
weigh
week
end
studi
death
weight
loss
consid
signific
postchalleng
clinic
examin
anim
display
seriou
irrevers
clinic
sign
lead
suffer
human
euthanis
whole
blood
collect
regular
interv
vaccin
challeng
select
sera
test
presenc
microscop
agglutin
titr
mat
colleg
veterinari
medicin
diagnost
laboratori
univers
minnesota
st
paul
usa
studi
affsa
laboratoir
de
recherch
rinair
alfort
pari
franc
studi
sera
test
l
interrogan
serovar
icterohaemorrhagia
canicola
use
standard
procedur
sinc
serolog
limit
valu
evalu
efficaci
vaccin
leptospirosi
sera
studi
test
antibodi
titr
express
reciproc
highest
serum
dilut
induc
least
studi
studi
agglutin
calcul
geometr
mean
titr
gmt
valu
lower
limit
quantif
lloq
replac
edta
blood
sampl
collect
dog
studi
least
day
challeng
daili
day
challeng
count
platelet
perform
use
cell
counter
analys
melet
schloes
franc
platelet
count
compar
report
standard
valu
dog
plateletsl
kahn
follow
test
perform
dog
studi
whole
blood
sampl
collect
challeng
day
challeng
sera
analyz
urea
nitrogen
creatinin
total
bilirubin
serum
glutam
oxalacet
transaminas
sgot
serum
glutamin
pyruv
transaminas
sgpt
laboratoir
marcel
rieux
lyon
franc
urea
nitrogen
creatinin
total
bilirubin
compar
normal
valu
provid
laboratori
mani
prechalleng
valu
sgot
sgpt
outsid
report
normal
valu
larg
modif
baselin
valu
taken
account
blood
sampl
collect
heparin
tube
challeng
day
day
challeng
studi
addit
blood
sampl
taken
day
blood
sampl
immedi
inocul
semisolid
medium
drop
blood
ml
medium
studi
liquid
emjh
medium
ml
blood
ml
medium
studi
transfer
lab
serial
dilut
made
media
incub
cultur
incub
week
observ
weekli
presenc
leptospir
use
dark
field
microscopi
urin
sampl
collect
challeng
day
day
week
challeng
studi
direct
bladder
tap
time
euthanasia
studi
studi
urin
sampl
collect
either
spontan
subcutan
inject
diuret
furosemid
dimazon
intervet
franc
mlkg
bodyweight
femal
probe
urethra
cathet
male
fluorouracil
ad
concentr
mgml
urin
sampl
studi
sampl
kidney
studi
liver
studi
collect
asept
approxim
g
organ
tissu
macer
ml
cultur
medium
vortex
tissu
debri
allow
settl
serial
dilut
made
urin
organ
cultur
made
describ
blood
cultur
immedi
euthanasia
death
anim
necropsi
subject
macroscop
examin
sampl
kidney
liver
fix
buffer
formalin
frozen
process
microscop
examin
follow
standard
procedur
organ
sampl
studi
submit
microscop
examin
histolog
section
stain
haematoxylineosin
warthinstarri
silver
stain
detect
leptospir
statist
analys
carri
use
statgraph
softwar
sa
releas
softwar
level
signific
set
p
sever
clinic
sign
sick
score
compar
among
vaccin
control
group
within
one
studi
assign
dog
one
two
diseas
categori
mild
clinic
diseas
moderatetosever
clinic
diseas
sick
score
calcul
use
daili
score
clinic
sign
basi
algorithm
gave
tripl
weight
score
jaundic
haematuria
thu
sick
score
daili
score
conjunctivitisir
daili
score
anorexia
daili
score
diarrhoeavomit
daili
score
gener
appear
daili
score
jaundic
daili
score
haematuria
dog
classifi
accord
sever
daili
score
record
challeng
observ
period
score
diseas
mild
diseas
moder
diseas
sever
diseas
differ
incid
moderatetosever
diseas
score
among
group
analyz
use
fischer
exact
test
leptospiremia
found
vaccin
pup
studi
statist
analysi
perform
daili
score
attribut
anim
studi
accord
result
blood
cultur
neg
posit
dilut
posit
dilut
posit
dilut
durat
leptospiraemia
cumul
score
first
day
postchalleng
area
timetitr
curv
compar
vaccin
control
dog
use
onesid
student
ttest
studi
wilcoxon
test
studi
dog
least
one
posit
urin
kidney
cultur
defin
renal
carrier
differ
incid
renal
carrier
among
group
analyz
use
fischer
exact
test
platelet
count
vaccin
adult
control
group
compar
use
wilcoxon
test
studi
mix
model
repeat
measur
studi
sgot
sgpt
valu
vaccin
control
group
compar
use
wilcoxon
test
chisquar
test
respect
prior
vaccin
none
dog
detect
antibodi
titr
l
interrogan
serovar
icterohaemorrhagia
canicola
vaccin
dog
studi
detect
antibodi
titr
day
challeng
l
interrogan
serovar
canicola
gmt
rang
l
interrogan
serovar
icterohaemorrhagia
gmt
rang
booster
effect
observ
one
nine
eight
nine
dog
l
interrogan
serovar
icterohaemorrhagia
canicola
challeng
respect
high
antibodi
titr
observ
surviv
control
l
interrogan
serovar
icterohaemorrhagia
gmt
l
interrogan
serovar
canicola
challeng
gmt
rang
challeng
antibodi
titr
higher
averag
surviv
control
vaccin
four
nine
dog
studi
detect
antibodi
titr
l
interrogan
serovar
icterohaemorrhagia
week
second
vaccin
rang
l
interrogan
serovar
icterohaemorrhagia
challeng
studi
seven
nine
dog
detect
antibodi
titr
l
interrogan
serovar
canicola
week
second
vaccin
rang
two
nine
anim
still
low
mat
antibodi
titr
day
challeng
incid
moder
sever
diseas
vaccin
control
dog
studi
shown
tabl
eight
control
pup
studi
becam
ill
l
interrogan
serovar
canicola
challeng
seven
pup
develop
sever
one
pup
moder
diseas
affect
pup
depress
frequent
observ
curl
food
bowl
anim
vomit
slightli
dehydr
haematuria
also
foul
smell
bloodi
diarrhoea
one
pup
develop
jaundic
day
postchalleng
four
pup
sever
clinic
diseas
human
euthanis
day
postchalleng
dpc
contrast
vaccin
pup
show
mild
transient
sign
two
vaccin
pup
slight
conjunct
one
pup
develop
mild
digest
sign
last
day
incid
moder
sever
diseas
significantli
lower
vaccin
pup
control
pup
p
fisher
exact
test
control
pup
studi
develop
clinic
sign
follow
l
interrogan
serovar
icterohaemorrhagia
challeng
six
control
pup
human
euthanis
sever
diseas
dpc
clinic
sign
similar
dog
challeng
l
interrogan
serovar
icterohaemorrhagia
canicola
includ
depress
anorexia
haemorrhag
diarrhoea
vomit
icteru
haematuria
three
control
pup
show
mild
clinic
sign
consist
depress
mild
diarrhoea
one
control
pup
show
clinic
sign
one
vaccin
pup
depress
dpc
incid
moder
sever
diseas
significantli
lower
vaccin
pup
control
pup
p
fisher
exact
test
two
control
puppi
ad
time
challeng
studi
die
sever
leptospirosi
dpc
valid
challeng
expect
clinic
sign
adult
control
less
sever
control
pup
nevertheless
four
control
dog
develop
moder
one
dog
sever
leptospirosi
latter
dog
human
euthanis
dpc
shown
characterist
sign
frank
leptospirosi
clinic
sign
moder
ill
dog
includ
conjunct
mild
diarrhoea
dehydr
weight
loss
five
seven
vaccin
dog
show
clinic
sign
observ
period
one
vaccin
dog
show
conjunct
dpc
two
dog
mild
diarrhoea
consecut
day
start
dpc
incid
moder
sever
diseas
significantli
differ
vaccin
control
dog
p
fisher
exact
test
studi
one
two
control
puppi
ad
time
challeng
die
dpc
develop
sever
diseas
sick
score
recov
unexpectedli
challeng
appear
sever
adult
control
three
control
dog
human
euthanis
depress
diarrhoea
dehydr
jaundic
one
dog
dpc
two
dog
one
dog
respect
five
control
mild
diseas
consist
conjunct
depress
anorexia
two
control
diseas
clinic
sign
vaccin
dog
mild
conjunct
one
dog
absent
incid
moder
sever
diseas
significantli
differ
vaccin
control
dog
p
fisher
exact
test
due
small
number
dog
posteriori
power
test
low
detect
signific
differ
twentyon
dog
per
group
would
need
detect
differ
probabl
equal
thrombocytopenia
record
challeng
vaccin
dog
studi
except
one
vaccin
dog
day
postl
interrogan
serovar
icterohaemorrhagia
challeng
contrast
studi
studi
control
becam
thrombocytopen
challeng
day
postchalleng
period
platelet
count
significantli
lower
control
vaccin
l
interrogan
serovar
canicola
challeng
p
mix
model
differ
close
signific
p
wilcoxon
test
l
interrogan
serovar
icterohaemorrhagia
challeng
sharp
increas
urea
creatinin
bilirubin
sgot
sgpt
valu
found
challeng
three
adult
control
studi
two
control
puppi
ad
studi
time
challeng
dog
develop
sever
clinic
diseas
three
adult
dog
one
two
puppi
succumb
challeng
contrast
none
vaccin
increas
urea
abbrevi
v
vaccin
c
control
studi
onset
immun
l
interrogan
serovar
canicola
studi
onset
immun
l
interrogan
serovar
icterohaemorrhagia
studi
durat
immun
l
interrogan
serovar
canicola
studi
durat
immun
l
interrogan
serovar
icterohaemorrhagia
bracket
number
dog
die
euthanis
challeng
fisher
exact
test
creatinin
bilirubin
valu
larg
modif
baselin
valu
sgpt
record
two
vaccin
dog
overview
result
provid
fig
studi
b
studi
tabl
studi
studi
blood
sampl
studi
neg
leptospir
challeng
leptospir
could
isol
blood
control
studi
least
day
follow
challeng
leptospiraemia
persist
day
l
interrogan
serovar
icterohaemorrhagia
canicola
respect
none
vaccin
dog
studi
develop
leptospiraemia
indic
infect
establish
vaccin
dog
control
puppi
studi
ad
time
challeng
develop
leptospiraemia
leptospir
could
isol
vaccin
control
dog
studi
total
amount
leptospira
isol
blood
first
day
challeng
significantli
lower
vaccin
dog
control
dog
p
onesid
student
ttest
addit
durat
leptospiraemia
significantli
shorter
vaccin
dog
compar
control
dog
p
student
ttest
control
dog
seven
nine
vaccin
dog
studi
develop
leptospiraemia
amount
durat
leptospiremia
significantli
reduc
vaccin
dog
compar
control
dog
p
wilcoxon
test
overview
result
given
fig
studi
b
studi
tabl
studi
studi
urin
sampl
studi
neg
leptospir
fig
result
blood
urin
kidney
cultur
challeng
puppi
l
interrogan
serovar
canicola
puppi
challeng
week
primari
cours
two
dose
vaccin
studi
onset
immun
b
result
blood
urin
kidney
cultur
challeng
puppi
l
interrogan
serovar
icterohaemorrhagia
puppi
challeng
week
primari
cours
two
dose
vaccin
studi
onset
immun
result
blood
urin
kidney
cultur
challeng
dog
l
interrogan
serovar
canicola
dog
challeng
month
primari
cours
two
dose
vaccin
studi
durat
immun
dog
day
challeng
blood
urin
kidney
challeng
leptospir
could
isol
kidney
control
dog
urin
control
dog
studi
respect
contrast
none
vaccin
dog
studi
posit
urin
kidney
cultur
time
euthanasia
proport
dog
renal
infect
character
presenc
leptospir
urin
andor
kidney
significantli
lower
vaccin
dog
compar
control
dog
studi
tabl
seven
eight
adult
control
dog
studi
shed
l
interrogan
serovar
canicola
urin
kidney
three
control
dog
cultur
posit
leptospir
could
isol
urin
two
vaccin
dog
kidney
one
vaccin
dog
incid
renal
carrier
significantli
lower
vaccin
dog
control
dog
p
fisher
exact
test
tabl
urin
could
collect
nine
adult
control
dog
studi
l
interrogan
serovar
icterohaemorrhagia
could
recov
urin
eight
dog
kidney
five
dog
liver
none
vaccin
dog
shed
leptospir
urin
leptospir
could
isol
kidney
liver
postmortem
examin
incid
renal
carriag
significantli
lower
vaccin
dog
compar
control
dog
p
fisher
exact
test
tabl
macroscop
lesion
detect
necropsi
similar
dog
studi
die
human
euthanis
due
termin
ill
gross
find
includ
haemorrhag
surfac
lung
abdomin
caviti
presenc
red
stain
fluid
pleural
abdomin
caviti
kidney
enlarg
friabl
urin
present
anim
ting
blood
sever
haematur
typic
faecal
materi
liquid
ting
blood
fetid
odour
dog
sclera
gingiv
subcutan
tissu
jaundic
apart
reactiv
mesenter
lymph
node
control
dog
surviv
experiment
tabl
result
blood
urin
kidney
cultur
challeng
dog
l
interrogan
serovar
icterohaemorrhagia
dog
challeng
month
primari
cours
two
dose
vaccin
studi
durat
immun
dog
day
challeng
blood
urin
kidney
day
death
day
death
vaccin
control
adult
cultur
posit
dilut
cultur
posit
dilut
cultur
posit
dilut
cultur
neg
c
contamin
die
euthanis
ns
sampl
infect
appear
normal
gross
visual
examin
well
vaccin
dog
promin
lesion
kidney
termin
ill
control
dog
includ
subacut
sever
interstiti
glomerulonephr
tubular
degener
moder
sever
diffus
hepat
lesion
found
dog
jaundic
mostli
consist
acut
degen
hepat
character
hepatocellular
dissoci
necrosi
interestingli
three
surviv
control
dog
studi
evid
subacut
multifoc
interstiti
nephriti
compat
leptospirosi
infect
specif
lesion
found
vaccin
dog
kidney
dog
diagnos
acut
renal
failur
stain
posit
warthinstarri
silver
indic
presenc
leptospir
number
factor
must
consid
design
evalu
efficaci
trial
canin
leptospirosi
vaccin
factor
includ
age
dog
recommend
vaccin
schedul
select
challeng
strain
challeng
method
ultim
goal
vaccin
leptospirosi
protect
dog
clinic
diseas
well
establish
renal
carrier
state
latter
protect
especi
import
carrier
dog
public
health
hazard
close
contact
human
center
diseas
control
trevejo
et
al
therefor
leptospirosi
vaccin
test
model
reliabl
produc
seri
clinic
sign
renal
colon
pattern
vaccin
design
prevent
reduc
canin
leptospirosi
difficult
diseas
reproduc
experiment
condit
usual
requir
use
young
puppi
high
challeng
dose
keenan
et
al
furthermor
clinic
sign
may
vari
depend
isol
greenle
et
al
alter
express
bacteri
protein
result
cultur
passag
greenle
et
al
time
harvest
hamster
passag
mink
person
observ
even
take
factor
account
report
infect
control
dog
often
result
evid
subclin
diseas
broughton
scarnel
studi
sever
lethal
diseas
report
follow
experiment
infect
dog
l
interrogan
serovar
canicola
schreiber
et
al
kerr
marshal
l
interrogan
serovar
icterohaemorrhagia
schreiber
et
al
kerr
marshal
studi
puppi
experiment
infect
l
interrogan
serovar
icterohaemorrhagia
canicola
develop
spectrum
diseas
rang
mild
lethal
sever
renal
hepat
hematolog
sign
domin
clinic
present
support
polysystem
natur
leptospira
infect
overal
mortal
rate
control
puppi
l
interrogan
serovar
icterohaemorrhagia
canicola
respect
extrem
challeng
condit
clinic
sign
vaccin
pup
rare
observ
mild
transient
natur
clinic
diseas
adult
dog
less
sever
unexpectedli
abl
induc
morbid
mortal
adult
dog
well
demonstr
sever
challeng
model
result
sharp
contrast
publish
klaasen
et
al
evid
clinic
symptom
associ
canin
leptospirosi
observ
adult
control
dog
reason
differ
clear
may
attribut
choic
challeng
strain
andor
challeng
dose
hematolog
paramet
blood
biochemistri
intend
major
criterion
assess
efficaci
vaccin
support
diagnosi
leptospirosi
thrombocytopenia
main
hematolog
abnorm
observ
control
dog
challeng
vaccin
dog
protect
thrombocytopenia
hematolog
disord
common
find
canin
leptospirosi
green
report
experiment
challeng
tronel
et
al
fontain
et
al
klaasen
et
al
schreiber
et
al
b
blood
biochemistri
illustr
alter
hepat
renal
function
control
dog
signific
chang
urea
nitrogen
creatinin
bilirubin
sgot
sgpt
observ
control
dog
sever
clinic
sign
increas
level
sgpt
two
vaccin
dog
correl
clinic
observ
rule
massiv
challeng
induc
transient
liver
damag
dog
necropsi
macroscop
examin
anim
consist
clinic
sign
typic
lesion
leptospirosi
observ
dog
succumb
challeng
addit
microscop
analysi
show
even
surviv
control
lesion
interstiti
nephriti
compat
leptospirosi
wherea
specif
lesion
observ
vaccin
dog
second
object
studi
determin
whether
eurican
l
would
protect
dog
develop
renal
carrier
state
mani
instanc
isol
result
kidney
urin
sampl
concord
studi
defin
renal
carrier
dog
least
one
posit
urin
kidney
cultur
discrep
urin
kidney
isol
result
also
report
literatur
attribut
presenc
specif
inhibit
enzym
kidney
cell
fain
high
urin
osmolar
ph
nervig
garrett
fact
leptospir
shed
intermitt
nervig
garrett
overal
found
control
pup
adult
control
becam
renal
carrier
despit
heavi
challeng
none
vaccin
puppi
vaccin
adult
dog
develop
renal
carrier
state
stress
challeng
dose
use
probabl
much
higher
observ
natur
infect
suggest
protect
renal
carriag
might
almost
complet
field
literatur
conflict
report
efficaci
leptospir
bacterin
protect
renal
carrier
state
much
variabl
like
result
differ
immunogen
bacterin
use
demonstr
fontain
et
al
studi
one
three
commerci
vaccin
complet
protect
dog
establish
renal
carrier
state
shortli
primovaccin
challeng
model
induc
mortal
sever
clinic
diseas
one
six
control
puppi
cultur
appear
sensit
hand
silver
stain
detect
leptospir
kidney
addit
advantag
infecti
materi
detect
rather
fragment
bacteria
explor
altern
detect
method
like
pcr
immunofluoresc
typic
serolog
find
present
studi
rel
low
shortliv
antibodi
respons
serovar
vaccin
sever
studi
report
low
antibodi
respons
administr
leptospirosi
inactiv
vaccin
fontain
et
al
schreiber
et
al
klaasen
et
al
stegerlieb
et
al
furthermor
correl
could
establish
antibodi
titr
vaccin
protect
experiment
infect
absenc
correl
classic
describ
studi
well
broughton
scarnel
fontain
et
al
klaasen
et
al
schreiber
et
al
conclud
primari
cours
two
dose
eurican
l
provid
quick
onset
longterm
protect
clinic
leptospirosi
renal
carrier
stage
vaccin
provid
veterinarian
power
tool
prevent
clinic
diseas
dog
zoonot
transmiss
leptospirosi
human
